Begin typing your search above and press return to search.

Russia plans mass COVID-19 vaccination from October; doctors, teachers top priority

He also informed that they are preparing a mass vaccination campaign against the novel coronavirus for October

coronavirus, Covid-19, coronavirus vaccine, Covid-19 human trials, Russia COVID 19 news

Sentinel Digital DeskBy : Sentinel Digital Desk

  |  2 Aug 2020 8:13 AM GMT

Amid the growing number of deadly coronavirus infections and deaths across the world, Russia's health minister stated the authorities are considering getting doctors and teachers vaccinated against the virus first, according to a report.

Russian Health Minister Mikhail Murashko also informed Gamaleya Institute of Epidemiology and Microbiology, a state research facility in Moscow, had completed clinical trials of the vaccine and paperwork is being prepared to register it.

"The vaccine against coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials," Murashko told reporters, answering a question about whether the clinical trials of the vaccine are officially completed, according to Sputnik News.

He also informed that they are preparing a mass vaccination campaign against the novel coronavirus for October, said Reuters citing local news agencies' reports.

"We plan wider vaccinations for October," Murashko said, Reuters reported.

As per reports, Russia's first potential Covid-19 vaccine would secure local regulatory approval in August and be administered to health workers soon thereafter.

Murashko also added that the health ministry expects at least two requests to begin clinical trials in the coming two months.

"We expect at least two more applications in the next one and a half to two months for permission to conduct clinical trials," Murashko also stated.

According to reports, earlier, Russia stated that it plans to register a coronavirus vaccine as soon as 10 August to 12 August, which can also be touted as the world's first Covid-19 vaccine.

Notably, the drug developed by Moscow's Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to seven days of registration by regulators, according to a person familiar with the process, who asked not to be identified because the information isn't public.

However, the Russian Defence Ministry declared that tests of the vaccine against coronavirus are being examined in full compliance with methodological regulations, with no attempts to reduce the duration of the research.

Last week, Military volunteers completed Phase 2 trials of the drug.

However, Russia registered 5,462 Covid-19 cases, bringing the cumulative total to 845,443, the country's coronavirus response centre said on Saturday.

ALSO WATCH: Education Policy to Benefit All Students: ABVP

Next Story